Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Divestments (2022 - 2023)

Pasithea Therapeutics (KTTA) has disclosed Divestments for 2 consecutive years, with $319618.0 as the latest value for Q2 2023.

  • Quarterly Divestments rose 173.94% to $319618.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $323807.0 through Dec 2023, up 151.65% year-over-year, with the annual reading at $323807.0 for FY2023, 151.65% up from the prior year.
  • Divestments hit $319618.0 in Q2 2023 for Pasithea Therapeutics, up from $4189.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $319618.0 in Q2 2023 to a low of -$432291.0 in Q2 2022.